TrialsgrambetaRCTs are beautiful

VASST

2008

Vasopressin and Septic Shock Trial

In 778 patients with septic shock on ≥5 µg/min norepinephrine, low-dose vasopressin added to norepinephrine did not reduce 28-day mortality compared with norepinephrine alone.

Result

28-day all-cause mortality
Absolute difference
3.9 points

The absolute difference is derived from the event rates.

Also reported: Less-severe subgroup 26.5% vs 35.7% (p=0.05; hypothesis-generating).

Original publication
Subtopic
Vasopressors
Design
Double-blind RCT
Relevance
Important: one of several pillars.
Source
Russell JA, et al. N Engl J Med. 2008;358(9):877-887.doi 10.1056/NEJMoa067373

Discussion & critique

Vasopressin is a safe catecholamine-sparing adjunct; routine in most modern septic-shock protocols.